Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent Biosciences, Inc.

11.36
-0.6900-5.73%
Post-market: 11.450.0900+0.79%19:28 EDT
Volume:2.49M
Turnover:28.69M
Market Cap:1.58B
PE:-5.58
High:12.02
Open:12.02
Low:11.33
Close:12.05
Loading ...

Scotiabank Sticks to Its Buy Rating for Cogent Biosciences (COGT)

TIPRANKS
·
08 Jul

Guggenheim Sticks to Their Buy Rating for Cogent Biosciences (COGT)

TIPRANKS
·
08 Jul

Cogent Biosciences Is Maintained at Outperform by Leerink Partners

Dow Jones
·
08 Jul

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Reuters
·
08 Jul

Cogent Biosciences Up Nearly 31%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk

Dow Jones
·
07 Jul

Jefferies Adjusts Price Target on Cogent Biosciences to $28 From $23, Maintains Buy Rating

MT Newswires Live
·
07 Jul

Cogent Biosciences trading halted, volatility trading pause

TIPRANKS
·
07 Jul

Cogent Biosciences Shares Rise After Mastocytosis Treatment Reaches Primary Endpoint in Recent Study

Dow Jones
·
07 Jul

BUZZ-Cogent surges on trial win for blood disorder drug

Reuters
·
07 Jul

Cogent Biosciences Inc. Announces Positive Results from SUMMIT Trial, Plans NDA Submission for Bezuclastinib by End of 2025

Reuters
·
07 Jul

Cogent announces statistical significance across all endpoints from SUMMIT trial

TIPRANKS
·
07 Jul

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

GlobeNewswire
·
07 Jul

Citi adds ‘upside 30-day catalyst watch’ on Cogent Biosciences

TIPRANKS
·
30 Jun

Piper Sandler Keeps Their Buy Rating on Cogent Biosciences (COGT)

TIPRANKS
·
25 Jun

Needham Sticks to Their Hold Rating for Cogent Biosciences (COGT)

TIPRANKS
·
17 Jun

Cogent Biosciences secures up to $400M in non-dilutive financing

TIPRANKS
·
11 Jun

Press Release: Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

Dow Jones
·
11 Jun

Cogent Biosciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
29 May

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

GlobeNewswire
·
29 May

U.S. RESEARCH ROUNDUP-Claritev, Rocket Pharmaceuticals, Salesforce

Reuters
·
29 May